Amplatzer™ Talisman™ PFO Occluder

AMPLATZER™ TALISMAN™
PFO OCCLUDER
STRUCTURAL INTERVENTIONS

Effective patent foramen ovale (PFO) closure is made easier with the
Amplatzer™ Talisman™ PFO Occluder.¹For patients who have experienced
a PFO-associated stroke, clinical trials have shown that they can benefit from
PFO closure.^2–4This minimally invasive procedure significantly reduces the risk
of recurrent ischemic stroke and offers an excellent safety profile.

SWITCH TO THE REFERRAL VIEW For more information specific to neurology regarding PFO closure

ADVANCING THE GOLD STANDARD IN PFO CLOSURE

For decades, interventional cardiologists have trusted the Amplatzer™ PFO Occluder for ease of use, safety, and excellent clinical outcomes.²With our latest addition, the Amplatzer™ Talisman™ PFO Occlusion System, the easy to use just got easier:

The occluder comes assembled and ready to use, streamlining preparation and enhancing the user experience
We have re-engineered the 30 mm size with a smaller left atrial disc to better avoid interference with surrounding structures

Often Imitated, Never Matched

Unique design features set the Amplatzer™ Talisman™ PFO Occluder apart from the rest.

*Only the 18 mm size is not asymmetric
^†Effective closure

Minimizing Complexity in PFO Closure

SIMPLIFIED PREPARATION

Occuluder comes assembled to the flexible Trevisio™ delivery cable, ready to use

RECAPTURABLE &
REPOSITIONABLE

Self-expanding discs align to the PFO without an additional “locking” step and can be adjusted for ideal placement

LOW PROFILE DELIVERY

8 F and 9 F sheaths enable treatment of patients with smaller vasculature

NEW VERSION AVAILABLE
GET THE AMPLATZER™ PORTFOLIO APP

The Amplatzer™ Portfolio App helps physicians determine which Amplatzer Structural Interventions device to use by suggesting applicable devices based on respective Instructions for Use.

Connext
Live

Bringing together the cardiovascular and stroke prevention community for live virtual events with the most respected KOLs.

Find out more

TV

Left Atrial Appendage Occlusion (LAAO)

Atrial Septal Defects (ASD)

Anatomical overview of the heart

Anatomical overview of the heart with focus on ASD, PFO and LAAO

Webinar on the latest clinical outcomes on PFO

Webinar PFO closure in patients >60 Years

Webinar PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

Valentina's testimonial

Valentina's PFO patient testimonial

Echo course PFO

Echo guidance for screening and interventions in PFO closure

Amplatzer™ manufacturing video: nitinol

Manufacture of Amplatzer™ occluders using nitinol wire

PFO closure animated procedure

Amplatzer™ Talisman™ PFO Occluder closure animated implantation procedure

Abbott_AlanButcher_patientstory_subtitles_HD - AHT Stroke prevention

Alan's Testimonial

Alan's PFO patient testimonial

Patent Foramen Ovale Patient Management

Christian Pristipino provides an overview of the clinical impact of updated guidance in PFO management, following publication of the European position paper.

References

Data on file at Abbott.
Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377(11):1022–1032. doi.org/10.1056/NEJMoa1610057.
Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033–1042. doi.org/10.1056/NEJMoa1707404.
Mas J-L, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377(11):1011–1021 and supplementary appendix. doi.org/10.1056/NEJMoa1705915.
Messé SR, Gronseth GS, Kent DM, et al. Practice advisory update summary: patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology. Neurology. 2020;94(20):876–885. doi.org/10.1212/WNL.0000000000009443.